Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Cambier

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Soins; La Revue De Reference Infirmiere|April 3, 2008
[Different types of leukemias]Nathalie Cambier, Agnès Charpentier
European Journal of Haematology|April 13, 2006
Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patientsChristian Rose, Philippe Vandevenne, Emmanuelle Bourgeois, et al.
Joint Bone Spine|May 7, 2010
Isolated megakaryoblastic bone sarcoma revealing acute myeloproliferative syndromeArnaud Desplechin, Arsène Mekinian, Julien Rossignol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Acute myocarditis induced by hypomethylating agentsJean-Emmanuel Bibault, Nathalie Cambier, Jean-Michel Lemahieu, et al.
Hemoglobin|August 21, 2015
Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase GeneAlexandra Forestier, Serge Pissard, Justine Cretet, et al.
British Journal of Haematology|August 9, 2019
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practiceFrançoise Huguet, Jean-Michel Cayuela, Nathalie Cambier, et al.
Blood|July 25, 2008
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia veraJean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, et al.
Current Medical Research and Opinion|December 8, 2009
Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC studyMauricette Michallet, Michel Tulliez, Sélim Corm, et al.
European Journal of Haematology|May 21, 2021
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)Loïc Renaud, Jean Baptiste Bossard, Benjamin Carpentier, et al.
Haematologica|June 2, 2016
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemiaAgnès Charpentier, Aurélien Lebreton, Antoine Rauch, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Soins; La Revue De Reference Infirmiere|April 3, 2008
[Different types of leukemias]Nathalie Cambier, Agnès Charpentier
European Journal of Haematology|April 13, 2006
Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patientsChristian Rose, Philippe Vandevenne, Emmanuelle Bourgeois, et al.
Joint Bone Spine|May 7, 2010
Isolated megakaryoblastic bone sarcoma revealing acute myeloproliferative syndromeArnaud Desplechin, Arsène Mekinian, Julien Rossignol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Acute myocarditis induced by hypomethylating agentsJean-Emmanuel Bibault, Nathalie Cambier, Jean-Michel Lemahieu, et al.
Hemoglobin|August 21, 2015
Congenital Recessive Methemoglobinemia Revealed in Adulthood: Description of a New Mutation in Cytochrome b5 Reductase GeneAlexandra Forestier, Serge Pissard, Justine Cretet, et al.
British Journal of Haematology|August 9, 2019
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practiceFrançoise Huguet, Jean-Michel Cayuela, Nathalie Cambier, et al.
Blood|July 25, 2008
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia veraJean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, et al.
Current Medical Research and Opinion|December 8, 2009
Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC studyMauricette Michallet, Michel Tulliez, Sélim Corm, et al.
European Journal of Haematology|May 21, 2021
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)Loïc Renaud, Jean Baptiste Bossard, Benjamin Carpentier, et al.
Haematologica|June 2, 2016
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemiaAgnès Charpentier, Aurélien Lebreton, Antoine Rauch, et al.
Pageof 2